Cargando…
Prediction of Synergistic Drug Combinations for Prostate Cancer by Transcriptomic and Network Characteristics
Prostate cancer (PRAD) is a major cause of cancer-related deaths. Current monotherapies show limited efficacy due to often rapidly emerging resistance. Combination therapies could provide an alternative solution to address this problem with enhanced therapeutic effect, reduced cytotoxicity, and dela...
Autores principales: | Li, Shiqi, Zhang, Fuhui, Xiao, Xiuchan, Guo, Yanzhi, Wen, Zhining, Li, Menglong, Pu, Xuemei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8112211/ https://www.ncbi.nlm.nih.gov/pubmed/33986671 http://dx.doi.org/10.3389/fphar.2021.634097 |
Ejemplares similares
-
Therapeutic and prognostic potential of GPCRs in prostate cancer from multi-omics landscape
por: Li, Shiqi, et al.
Publicado: (2022) -
Probing the Druggablility on the Interface of the Protein–Protein Interaction and Its Allosteric Regulation Mechanism on the Drug Screening for the CXCR4 Homodimer
por: Shen, Liting, et al.
Publicado: (2019) -
A new molecular subclassification and in silico predictions for diagnosis and prognosis of papillary thyroid cancer by alternative splicing profile
por: Li, Haiyan, et al.
Publicado: (2023) -
Probing Immobilization Mechanism of alpha-chymotrypsin onto Carbon Nanotube in Organic Media by Molecular Dynamics Simulation
por: Zhang, Liyun, et al.
Publicado: (2015) -
Comparative Analysis for the Performance of Variant Calling Pipelines on Detecting the de novo Mutations in Humans
por: Liang, Yu, et al.
Publicado: (2019)